Total Funding
36
11
Total FundingDebt Financing raised
Growth Score
-2 pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
470489
Selah Genomics supports healthcare providers and the pharmaceutical industry with advanced molecular and genomic diagnostic services.
Acquired by 
EKF Diagnostics
Michael Bolick: Founder & CEOPast Role: Lab21, President
About the Company
Selah Genomics is a clinical diagnostic specialist supporting healthcare providers and the pharmaceutical industry with advanced molecular and genomic diagnostic services. Selah's services add value to early stage drug development, clinical trials and regulatory processes in the pharmaceutical industry and helps clinicians and healthcare
providers treat and monitor patients, thereby improving patient outcomes.
